[go: up one dir, main page]

PT71885B - Process for the preparation of ergot-peptide alkaloids having pharmaceutical effect - Google Patents

Process for the preparation of ergot-peptide alkaloids having pharmaceutical effect

Info

Publication number
PT71885B
PT71885B PT71885A PT7188580A PT71885B PT 71885 B PT71885 B PT 71885B PT 71885 A PT71885 A PT 71885A PT 7188580 A PT7188580 A PT 7188580A PT 71885 B PT71885 B PT 71885B
Authority
PT
Portugal
Prior art keywords
ergot
preparation
pharmaceutical effect
peptide alkaloids
alkaloids
Prior art date
Application number
PT71885A
Other languages
English (en)
Other versions
PT71885A (en
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT71885A publication Critical patent/PT71885A/pt
Publication of PT71885B publication Critical patent/PT71885B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02Ergot alkaloids of the cyclic peptide type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT71885A 1979-10-09 1980-10-07 Process for the preparation of ergot-peptide alkaloids having pharmaceutical effect PT71885B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH909679 1979-10-09

Publications (2)

Publication Number Publication Date
PT71885A PT71885A (en) 1980-11-01
PT71885B true PT71885B (en) 1981-12-17

Family

ID=4348271

Family Applications (1)

Application Number Title Priority Date Filing Date
PT71885A PT71885B (en) 1979-10-09 1980-10-07 Process for the preparation of ergot-peptide alkaloids having pharmaceutical effect

Country Status (11)

Country Link
EP (1) EP0026899A1 (pt)
JP (1) JPS5661392A (pt)
KR (1) KR830004323A (pt)
AU (1) AU6302180A (pt)
GR (1) GR70758B (pt)
IL (1) IL61222A0 (pt)
MA (1) MA18971A1 (pt)
PL (1) PL227153A1 (pt)
PT (1) PT71885B (pt)
WO (1) WO1981000961A1 (pt)
ZA (1) ZA806244B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4595962A3 (en) 2020-06-12 2025-10-22 Beckley Psytech Limited Pharmaceutical composition
EP4155306A1 (en) 2021-01-15 2023-03-29 Beckley Psytech Limited Neuroactive ergoline analogue
US12264131B2 (en) 2022-08-19 2025-04-01 Beckley Psytech Limited Pharmaceutically acceptable salts and compositions thereof
GB202212116D0 (en) 2022-08-19 2022-10-05 Beckley Psytech Ltd Pharmaceutically acceptable salts and Compositions thereof
US12246005B2 (en) 2023-06-13 2025-03-11 Beckley Psytech Limited 5-methoxy-n,n-dimethyltryptamine (5-MeO-DMT) formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH581136A5 (pt) * 1972-09-26 1976-10-29 Sandoz Ag
CH588486A5 (en) * 1973-08-23 1977-06-15 Sandoz Ag (13)-Bromo-beta-ergocryptine derivs. - prepd. from (13)-bromo-(9,10)-dihydro-lysergic acid
CH602766A5 (en) * 1974-09-27 1978-07-31 Sandoz Ag 10-Alpha-methoxy-di:hydro-beta-ergosine derivs.
CH610330A5 (en) * 1974-09-27 1979-04-12 Sandoz Ag Process for the preparation of novel ergopeptins
CH602764A5 (en) * 1974-09-27 1978-07-31 Sandoz Ag 10-Hydroxy or alkoxy-9,10-di:hydro-ergopeptin derivs.

Also Published As

Publication number Publication date
GR70758B (pt) 1983-03-16
PL227153A1 (pt) 1981-12-11
PT71885A (en) 1980-11-01
IL61222A0 (en) 1980-12-31
MA18971A1 (fr) 1981-07-01
EP0026899A1 (de) 1981-04-15
ZA806244B (en) 1982-05-26
JPS5661392A (en) 1981-05-26
WO1981000961A1 (fr) 1981-04-16
AU6302180A (en) 1981-04-16
KR830004323A (ko) 1983-07-09

Similar Documents

Publication Publication Date Title
DE3071625D1 (en) Process for the preparation of tablets
DE3060027D1 (en) Process for the preparation of benzimidazolylbenzofurans
PT71676A (en) Process for the preparation of new derivatives of 1h-indolhaving pharmaceutical properties
DE3060131D1 (en) Process for the direct preparation of beta-methylthio-propionaldehyde
DE3060155D1 (en) Process for the preparation of thiazolidine-2-thiones
DE3060854D1 (en) Process for the preparation of 3-phenoxybenzaldehydes
PT71913A (en) Process for the preparation of derivatives of benzodiazepine with pharmaceutical compounds
DE3063952D1 (en) Process for the preparation of riboflavin
DE3064993D1 (en) Process for the preparation of hexahydronaphthacene derivatives
PH22005A (en) Process for the preparation of new hemoserine derivatives
PT71582A (en) Process for the preparation of 3-methyleneazetidine derivatives
GB2042542B (en) Process for the preparation of meta-chloroanilines
PT71031B (en) Process for the preparation of benzodiazepine derivatives
DE3065967D1 (en) Process for the preparation of diorganomagnesium compounds
PT70716A (en) Process for the preparation of novel spiro-quinolylhydantoin derivatives
PT72237B (en) Process for the preparation of new pyrrolbenzotriazepines having pharmaceutical effect
PT71885B (en) Process for the preparation of ergot-peptide alkaloids having pharmaceutical effect
GB2098208B (en) Process for the preparation of 7-acylindolines
DE3062386D1 (en) Process for the preparation of 3-hydroxycepham compounds
GB2051053B (en) Process for the preparation of d-a-aminoacids
DE2964328D1 (en) Process for the preparation of m-amino-phenols
PT73413B (en) Process for the preparation of ergolin derivatives with pharmaceutical effect
PT71867B (en) Process for the preparation of phenanthroline-9-carboxylic acidderivatives having pharmaceutical properties
PT72338B (en) Process for the preparation of 2-aminomethyl-6-halphenols having pharmaceutical effect
PT71606B (en) Process for the preparation of benzodiazepine derivatives